OCRF & Ovarian Cancer National Alliance are now one strong, united, inspiring voice!
Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund Alliance (OCRFA), the largest global organization dedicated to advancing ovarian cancer research while supporting women and their families. Read the exciting news!

XClose

OCRFA News

Super Saturday Events Raise Close to $3.5 Million for OCRFA

Donna Karan, Kelly Ripa and Gabby Karan de Felice hosted Ovarian Cancer Research Fund Alliance’s (OCRFA) 19th annual Super Saturday NY. Guests in attendance included: June Ambrose, Joy Behar, Kelly Bensimon, Lorraine Bracco, Jonathan Cheban, Mayor Rudolph & Judith Giuliani, Katherine Jenkins,... 

OCRFA Founder Sol Schreiber passes away

(6/9/16) With deep sorrow, Ovarian Cancer Research Fund Alliance mourns the passing of our beloved founder and Chairman Emeritus, Sol Schreiber. We are profoundly grateful for his foresight in founding this organization, as well as his unwavering leadership through the years. His steady commitment to... 

Action Alert: Protect Ovarian Cancer Research Funding at the Department of Defense

Later this week, we’ll be sending out a request for you to take Action to help protect ovarian cancer research funding at the Department of Defense. The Ovarian Cancer Research Program (OCRP) is part of the Congressionally Directed Medical Research Program in the Department of Defense (DoD), and funds... 

Newk’s Unites 100 Restaurants to Raise $100,000 for Ovarian Cancer Research

Foodie Fast-Casual Brand Reaches Halfway Point in Its 200-Unit Growth Plan JACKSON, Miss. — Pairing a big moment with a big cause, fast-casual Newk’s Eatery is celebrating its centennial restaurant opening by uniting system-wide to raise $100,000 for ovarian cancer research starting April 4. Each... 

Stand Up To Cancer Supports “Innovation in Collaboration” in Cancer Research with $1 Million for Five Teams through Phillip A. Sharp Awards

May 2, 2016 – Stand Up To Cancer (SU2C) has awarded a total of $1 million to five teams of cancer researchers to advance “innovation in collaboration” among SU2C-­‐affiliated scientists. Each team, consisting of researchers from different SU2C-­‐supported “Dream Teams” or research programs,... 

OCRFA Statement on Results of GOG 252

April 11, 2016 – Many members of the ovarian cancer community have been concerned about the results of GOG 252 clinical trial, which were released last month at the Society of Gynecologic Oncology’s Annual Meeting on Women’s Cancer. OCRFA consulted with a team of our scientific experts, and... 

Strength in Numbers: OCRF and OCNA Unite to Form OCRFA

(1/26/16) Ovarian Cancer Research Fund (OCRF) and the Ovarian Cancer National Alliance (OCNA) have led the way in advocacy, research and support for patients and their families for over 22 years. As of January 2016, we are pleased to announce we are joining together to form Ovarian Cancer Research Fund... 

Ovarian Cancer National Alliance and Ovarian Cancer Research Fund Announce Merger, Formation of Ovarian Cancer Research Fund Alliance

Merger to create largest global ovarian cancer policy advocacy and research organization January 26, 2016 — Today, two of the nation’s foremost ovarian cancer policy advocacy and research organizations, the Ovarian Cancer National Alliance and Ovarian Cancer Research Fund announced a merger, forming... 

Team Twedt: Taking on Ovarian Cancer, One Ironman at a Time

(12/17/15) Ask anyone who’s taken on the grueling series of events that make up an Ironman competition–a 2.4 mile swim and 112 mile bike ride, followed by a 26.2 mile run–and they might tell you that when it comes to mentally preparing for this kind of challenge, sometimes it’s easier not to... 

Under the Microscope: OCRF’s 2015 Research Progress Report

(12/14/15) | In 2015, OCRF grantees made several significant advances in the fight against ovarian cancer, including: Pinpointing two genes that trigger ovarian cancer Identifying a new therapeutic strategy for clear cell ovarian cancer Discovering how a tailored surgical approach leads to better outcomes Finding...